NSAIDs and Kelleni’s protocol as potential early COVID-19 treatment game changer: could it be the final countdown?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Immunology
Link
https://link.springer.com/content/pdf/10.1007/s10787-021-00896-7.pdf
Reference52 articles.
1. Aranda JV, Salomone F, Valencia GB, Beharry KD (2017) Non-steroidal anti-inflammatory drugs in newborns and infants. Pediatr Clin North Am 64:1327–1340
2. Banerjee A, Czinn SJ, Reiter RJ, Blanchard TG (2020) Crosstalk between endoplasmic reticulum stress and anti-viral activities: a novel therapeutic target for COVID-19. Life Sci 255:117842
3. Blum VF, Cimerman S, Hunter JR, Tierno P, Lacerda A, Soeiro A et al (2021) Nitazoxanide superiority to placebo to treat moderate COVID-19: a pilot prove of concept randomized double-blind clinical trial. EClinicalMedicine 37:100981
4. Cadegiani FA, Goren A, Wambier CG, McCoy J (2021) Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known outcomes in untreated patients. New Microbes New Infect 43:100915
5. Cao L, Mu W (2021) Necrostatin-1 and necroptosis inhibition: pathophysiology and therapeutic implications. Pharmacol Res 163:105297–105297
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Association of using enteral nutrition containing probiotics and dietary inflammatory index with inflammatory factors serum levels and gastrointestinal complications in infected patients with COVID-19;Nutrition & Food Science;2024-04-30
2. COVID-19 mortality paradox (United States vs Africa): Mass vaccination vs early treatment;World Journal of Experimental Medicine;2024-03-20
3. Repurposing metformin to manage idiopathic or long COVID Tinnitus: self-report adopting a pathophysiological and pharmacological approach;Inflammopharmacology;2024-01-31
4. Analysis of clinical characteristics and risk factors between elderly patients with severe and nonsevere Omicron variant infection;World Journal of Clinical Infectious Diseases;2023-11-22
5. The African Kelleni’s roadmap using nitazoxanide and broad-spectrum antimicrobials to abort returning to COVID-19 square one;Inflammopharmacology;2023-06-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3